Anodyne Dental Pharma Announces the Appointment of Alan Barker to the Board of Directors

Share Article

Anodyne Dental Pharma, a Houston based specialty pharmaceutical company, announced today that it has elected Alan Barker to its Board of Directors.

Anodyne Dental Pharma, a Houston based specialty pharmaceutical company, announced today that it has elected Alan Barker to its Board of Directors. Mr. Barker is currently President of Barker Railway Supply as well as Vice President of Marketing for C.D.L. Electric and V.D.L. Transportation. Mr. Barker has served in several senior management positions including Senior Vice President at Railroad Signal Inc., Account Executive at Exel Transportation and Senior Vice President at Am Rail Construction.

“Alan brings a broad Management and Financial experience to Anodyne that will be a tremendous asset” stated Larry Lawhon, Founder and Chairman of Anodyne Dental Pharma, “we are excited to have him as part of our Board.” Larry Collins, CEO and President of Anodyne, stated “for more than thirty years, Alan has held a number of strategically important Marketing and Financial positions that will be an asset to Anodyne. We will benefit from his expertise and entrepreneurial experience, especially at this significant point in Anodyne’s growth.”

About Anodyne Dental Pharma

Anodyne Dental Pharma, Inc. (“Anodyne”) is a Houston based product-oriented pharmaceutical company with the sole focus of serving the dental pharmaceutical marketplace. Anodyne is headquartered in Houston, TX. Through its national sales force, Anodyne markets directly to Pharmaceutical Wholesalers, Independent Retail Pharmacies, Pharmacy Chain Stores (e.g., Eckerd Drugs, Walgreen's and CVS), Chain Dental Clinics, Private Dental Offices, Dental Schools, and 431 Government Clinics.

Anodyne is the only pharmaceutical development/sales company that focuses solely on the dental community.


Investor Relations

Robert Capaldo

Madison Keats

704-377-4121    Ex 1022

Anodyne Dental Pharma

Larry Collins, CEO and President

Statements contained in this press release, which are not historical facts, are forward-looking statements, as the term is defined in the Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by the use of words such as, “expects,” “plans,” “estimates,” “projects,” “intends,” “believes,” and similar expressions that do not relate to historical matters. Such forward-looking statements are subject to risks and uncertainties which can cause actual results to differ materially from those currently anticipated, due to a number of factors., All forward-looking statements in this press release are made as of today, based upon information known to management as of the date hereof. Anodyne Dental Pharma assumes no obligation to update or revise any of its forward-looking statements even if experience or future changes show that indicated results or events will not be realized.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Robert Capaldo
Anodyne Dental Pharma
Email >